Literature DB >> 32047930

Hemolytic anemia associated with dapsone PCP prophylaxis in GBM patients with normal G6PD activity.

Lisa R Rogers1, Peter Oppelt2, Lalitha Nayak3.   

Abstract

Entities:  

Keywords:  dapsone; glioblastoma; hemolytic anemia

Mesh：

Substances：

Year:  2020        PMID： 32047930      PMCID： PMC7283030          DOI： 10.1093/neuonc/noaa026

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  5 in total

1.  Acute hemolysis in a patient with a newly diagnosed glioblastoma.

Authors:  Adrian G Murphy; Stuart A Grossman
Journal:  CNS Oncol       Date:  2016-05-27

2.  High prevalence of Dapsone-induced oxidant hemolysis in North American SCT recipients without glucose-6-phosphate-dehydrogenase deficiency.

Authors:  H Olteanu; A M Harrington; B George; P N Hari; C Bredeson; S H Kroft
Journal:  Bone Marrow Transplant       Date:  2011-04-11       Impact factor: 5.483

3.  Dapsone-induced hemolytic anemia in lung allograft recipients.

Authors:  Priyumvada M Naik; G Marshall Lyon; Allan Ramirez; E Clinton Lawrence; David C Neujahr; Seth Force; Andres Pelaez
Journal:  J Heart Lung Transplant       Date:  2008-10-01       Impact factor: 10.247

4.  Family history of cancer in benign brain tumor subtypes versus gliomas.

Authors:  Quinn T Ostrom; Christopher McCulloh; Yanwen Chen; Karen Devine; Yingli Wolinsky; Perica Davitkov; Sarah Robbins; Rajesh Cherukuri; Ashokkumar Patel; Rajnish Gupta; Mark Cohen; Jaime Vengoechea Barrios; Cathy Brewer; Cathy Schilero; Kathy Smolenski; Mary McGraw; Barbara Denk; Theresa Naska; Frances Laube; Ruth Steele; Dale Greene; Alison Kastl; Susan Bell; Dina Aziz; E A Chiocca; Christopher McPherson; Ronald Warnick; Gene H Barnett; Andrew E Sloan; Jill S Barnholtz-Sloan
Journal:  Front Oncol       Date:  2012-02-28       Impact factor: 6.244

5.  Hemolytic anemia in two patients with glioblastoma multiforme: A possible interaction between vorinostat and dapsone.

Authors:  Jennifer A Lewis; William J Petty; Michele Harmon; James E Peacock; Kari Valente; John Owen; Munir Pirmohamed; Glenn J Lesser
Journal:  J Oncol Pharm Pract       Date:  2014-02-27       Impact factor: 1.809
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.